Eledon Pharmaceuticals, Inc. Payments to Acquire Marketable Securities
Eledon Pharmaceuticals, Inc. (ELDN) reported Payments to Acquire Marketable Securities of $500.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2017-03-03
- Eledon Pharmaceuticals, Inc. payments to acquire marketable securities for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- Eledon Pharmaceuticals, Inc. payments to acquire marketable securities for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Eledon Pharmaceuticals, Inc. payments to acquire marketable securities for the quarter ending 2015-12-31 was $100.00K.
- Eledon Pharmaceuticals, Inc. payments to acquire marketable securities for the quarter ending 2015-09-30 was $15.70M.
- Eledon Pharmaceuticals, Inc. payments to acquire marketable securities for fiscal 2016 was $500.00K, a 98.75% decline from fiscal 2015.
- Eledon Pharmaceuticals, Inc. payments to acquire marketable securities for fiscal 2015 was $39.88M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $0.00 derived: sum of 2 quarters · filed 2017-03-03 | $500.00K 10-K · filed 2017-03-03 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $500.00K 10-Q · filed 2016-11-03 | ||
| 2016-06-30 | $500.00K 10-Q · filed 2016-08-04 | |||
| 2015-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $15.80M derived: sum of 2 quarters · filed 2017-03-03 | $39.88M 10-K · filed 2017-03-03 | |
| 2015-09-30 | $15.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $39.77M 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $24.08M 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |